Answer
It closes beta-cell potassium channels and restores insulin release when particular genetic changes prevent those channels from closing normally.
Sources for this answer
- AMGLIDIA 0.6 mg/mL oral suspension with 1 mL oral syringe — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.